Targeting the osteoclastogenic cytokine IL-9 as a novel immunotherapeutic strategy in mitigating inflammatory bone loss in post-menopausal osteoporosis

JBMR Plus
September 14, 2024
Cited by 18


Related Papers

No related papers found

Powered by citation graph analysis